Treatments and vaccines for COVID-19
Medicines authorised in the European Union (EU) to treat or prevent COVID-19, following a scientific evaluation by the European Medicines Agency (EMA). It provides details on the other potential treatments and vaccines that EMA is evaluating or has provided support to during research and development.
COVID-19 vaccines under investigation, evaluation and authorised for use in the EU
COVID-19 treatments under investigation, evaluation and authorised for use in the EU
How EMA is monitoring safety and effectiveness of COVID-19 medicines.
EMA's exceptional measures to ensure its regulatory activities in relation to COVID-19 medicines are as transparent as possible.
EMA is assessing all applications for COVID-19 treatments and vaccines under the minimum timeframe necessary to allow a thorough evaluation of the medicine's benefits and risks, in accordance with its usual standards for quality, safety and effectiveness.